Also trades as: 0460.HK (HKSE) · $vol 3M
SHPHF OTC
Sihuan Pharmaceutical Holdings Group Ltd.
1W: +0.0%
1M: +0.0%
3M: -7.5%
YTD: -25.0%
1Y: +21.7%
3Y: +58.7%
5Y: -41.4%
$0.12
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$10.5B
-8.7% ▼
5Y CAGR: -3.5%
Total Liabilities
$5.6B
-12.8% ▼
5Y CAGR: +16.3%
Shareholders Equity
$4.4B
-1.4% ▼
5Y CAGR: -14.6%
Cash & Investments
$3.9B
-13.5% ▼
5Y CAGR: -5.9%
Total Debt
$974M
-22.5% ▼
5Y CAGR: +119.9%
Net Debt
-$2.6B
-0.5% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $4.6B | $5.7B | $3.8B | $3.9B | $3.6B |
| Short-Term Investments | $333M | $109M | $963M | $589M | $255M |
| Cash & ST Investments | $4.9B | $5.8B | $4.8B | $4.5B | $3.9B |
| Net Receivables | $390M | $779M | $522M | $398M | $1.3B |
| Inventory | $496M | $715M | $607M | $557M | $417M |
| Other Current Assets | $431M | $455M | $630M | $31M | -$7K |
| Total Current Assets | $6.4B | $7.7B | $6.6B | $6.2B | $5.7B |
| Property, Plant & Equip. | $3.8B | $4.1B | $3.0B | $2.8B | $2.6B |
| Goodwill & Intangibles | $323M | $460M | $596M | $657M | $844M |
| Long-Term Investments | $1.3B | $973M | $907M | $1.0B | $663M |
| Other Non-Current Assets | -$269M | -$303M | -$97M | $239M | $640M |
| Total Non-Current Assets | $5.4B | $5.5B | $4.5B | $5.3B | $4.8B |
| Total Assets | $13.0B | $14.5B | $12.1B | $11.5B | $10.5B |
| — Liabilities — | |||||
| Accounts Payable | $106M | $119M | $206M | $221M | $242M |
| Short-Term Debt | $392M | $200M | $341M | $287M | $203M |
| Deferred Revenue | $0 | -$205M | -$340M | $1.7B | $0 |
| Other Current Liabilities | $957M | $1.3B | $1.6B | $1.4B | $1.7B |
| Total Current Liabilities | $2.4B | $2.5B | $2.5B | $4.1B | $3.3B |
| Long-Term Debt | $359M | $845M | $849M | $927M | $747M |
| Other Non-Current Liab. | $0 | $1.7B | $2.8B | $1.1B | $1.2B |
| Total Non-Current Liabilities | $652M | $2.8B | $4.0B | $2.3B | $2.3B |
| Total Liabilities | $3.1B | $5.3B | $6.5B | $6.4B | $5.6B |
| — Equity — | |||||
| Common Stock | $78M | $77M | $77M | $77M | $77M |
| Retained Earnings | $4.6B | $4.9B | $1.7B | $946M | $941M |
| Accumulated OCI | $399M | -$597M | -$914M | -$440M | -$474M |
| Total Stockholders Equity | $9.2B | $8.3B | $4.7B | $4.4B | $4.4B |
| Total Liabilities & Equity | $13.0B | $14.5B | $12.1B | $11.5B | $10.5B |
| — Key Metrics — | |||||
| Total Debt | $755M | $1.1B | $1.3B | $1.3B | $974M |
| Net Debt | -$3.8B | -$4.6B | -$2.6B | -$2.6B | -$2.6B |
| Total Investments | $1.6B | $1.1B | $1.9B | $1.6B | $918M |